Biyun Lin

553 total citations
21 papers, 426 citations indexed

About

Biyun Lin is a scholar working on Molecular Biology, Pulmonary and Respiratory Medicine and Epidemiology. According to data from OpenAlex, Biyun Lin has authored 21 papers receiving a total of 426 indexed citations (citations by other indexed papers that have themselves been cited), including 13 papers in Molecular Biology, 5 papers in Pulmonary and Respiratory Medicine and 4 papers in Epidemiology. Recurrent topics in Biyun Lin's work include Epigenetics and DNA Methylation (3 papers), RNA modifications and cancer (3 papers) and Cancer-related gene regulation (3 papers). Biyun Lin is often cited by papers focused on Epigenetics and DNA Methylation (3 papers), RNA modifications and cancer (3 papers) and Cancer-related gene regulation (3 papers). Biyun Lin collaborates with scholars based in China and United States. Biyun Lin's co-authors include Haitao Zhang, Hui Luo, Lijuan Su, Jian Huang, Jun Wu, Yajun Wang, Benyi Li, Jun Wu, Xiaoyi Chen and Chuanxing Xiao and has published in prestigious journals such as PLoS ONE, European Journal of Pharmacology and Cancer Letters.

In The Last Decade

Biyun Lin

20 papers receiving 420 citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
Biyun Lin China 11 232 82 66 56 53 21 426
Bangxiang Xie China 10 191 0.8× 82 1.0× 93 1.4× 48 0.9× 37 0.7× 22 378
Jiaru Wang China 13 194 0.8× 64 0.8× 61 0.9× 63 1.1× 25 0.5× 38 457
Wei‐Heng Xu China 16 302 1.3× 101 1.2× 71 1.1× 79 1.4× 70 1.3× 31 630
Shu Dai China 13 193 0.8× 86 1.0× 61 0.9× 31 0.6× 47 0.9× 24 452
Nisansala Chandimali South Korea 14 300 1.3× 109 1.3× 106 1.6× 64 1.1× 28 0.5× 34 654
Deok Yong Sim South Korea 15 332 1.4× 48 0.6× 123 1.9× 100 1.8× 57 1.1× 39 497
Weilian Bao China 14 294 1.3× 113 1.4× 68 1.0× 56 1.0× 82 1.5× 26 523
Kang Cui China 11 242 1.0× 49 0.6× 101 1.5× 75 1.3× 31 0.6× 22 452
Shenghao Li China 12 166 0.7× 57 0.7× 42 0.6× 47 0.8× 42 0.8× 33 373
Haojie Du China 8 184 0.8× 74 0.9× 44 0.7× 41 0.7× 71 1.3× 19 446

Countries citing papers authored by Biyun Lin

Since Specialization
Citations

This map shows the geographic impact of Biyun Lin's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Biyun Lin with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Biyun Lin more than expected).

Fields of papers citing papers by Biyun Lin

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Biyun Lin. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Biyun Lin. The network helps show where Biyun Lin may publish in the future.

Co-authorship network of co-authors of Biyun Lin

This figure shows the co-authorship network connecting the top 25 collaborators of Biyun Lin. A scholar is included among the top collaborators of Biyun Lin based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Biyun Lin. Biyun Lin is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

20 of 20 papers shown
1.
Lin, Biyun & Yinwei Zhan. (2024). Self-supervised action representation learning from partial consistency skeleton sequences. Neural Computing and Applications. 36(20). 12385–12395.
2.
Li, Zeyan, et al.. (2023). Identification of DDIT4 as a potential prognostic marker associated with chemotherapeutic and immunotherapeutic response in triple-negative breast cancer. World Journal of Surgical Oncology. 21(1). 194–194. 6 indexed citations
3.
Huang, Ting, Cheng Lü, Ying Zhang, et al.. (2023). Effect of activating cancer-associated fibroblasts biomarker TNC on immune cell infiltration and prognosis in breast cancer. Annals of Medicine. 55(2). 2250987–2250987. 5 indexed citations
4.
Huang, Jian, Biyun Lin, & Benyi Li. (2022). Anti-Androgen Receptor Therapies in Prostate Cancer: A Brief Update and Perspective. Frontiers in Oncology. 12. 865350–865350. 34 indexed citations
5.
Huang, Jian, Wang Liu, Da Zhang, Biyun Lin, & Benyi Li. (2022). TMEM158 expression is negatively regulated by AR signaling and associated with favorite survival outcomes in prostate cancers. Frontiers in Oncology. 12. 1023455–1023455. 8 indexed citations
6.
Huang, Jian, et al.. (2022). Scaffold protein MAPK8IP2 expression is a robust prognostic factor in prostate cancer associated with AR signaling activity. Asian Journal of Andrology. 25(2). 198–207. 5 indexed citations
7.
Zeng, Yu, M Tai, Biyun Lin, et al.. (2021). Analysis of the Prognostic Value and Gene Expression Mechanism of SHOX2 in Lung Adenocarcinoma. Frontiers in Molecular Biosciences. 8. 688274–688274. 9 indexed citations
8.
Lin, Biyun, Hui Huang, Yaguang Hu, et al.. (2020). AQ-4, a deuterium-containing molecule, acts as a microtubule-targeting agent for cancer treatment. European Journal of Pharmacology. 877. 173093–173093. 5 indexed citations
9.
Yu, Huajun, Zhao Zhang, Hui Huang, et al.. (2019). Inhibition of bleomycin-induced pulmonary fibrosis in mice by the novel peptide EZY-1 purified from Eucheuma. Food & Function. 10(6). 3198–3208. 12 indexed citations
10.
Lin, Biyun, et al.. (2018). Research on Improving the Talent Incentive Mechanism of Artificial Intelligence Industry in China. Open Journal of Social Sciences. 6(4). 135–142. 1 indexed citations
11.
Lin, Biyun. (2018). The Accounting Analysis of the Intangible Cultural Heritage Enterprises’ Brand Value—Take the Chinese Medicine Industry as an Example. American Journal of Industrial and Business Management. 8(7). 1716–1731. 2 indexed citations
12.
Zhang, Junfang, Hualong Xiong, Jiali Cao, et al.. (2017). A cell-penetrating whole molecule antibody targeting intracellular HBx suppresses hepatitis B virus via TRIM21-dependent pathway. Theranostics. 8(2). 549–562. 58 indexed citations
13.
Wang, Yajun, Biyun Lin, Huimin Li, et al.. (2017). Galangin suppresses hepatocellular carcinoma cell proliferation by reversing the Warburg effect. Biomedicine & Pharmacotherapy. 95. 1295–1300. 31 indexed citations
14.
Wang, Yajun, Jun Wu, Biyun Lin, et al.. (2014). Galangin suppresses HepG2 cell proliferation by activating the TGF-β receptor/Smad pathway. Toxicology. 326. 9–17. 42 indexed citations
15.
Wang, Yajun, Biyun Lin, Jun Wu, Haitao Zhang, & Bin Wu. (2014). Metformin inhibits the proliferation of A549/CDDP cells by activating p38 mitogen-activated protein kinase. Oncology Letters. 8(3). 1269–1274. 24 indexed citations
16.
Zhang, Haitao, Ning Li, Jun Wu, et al.. (2013). Galangin inhibits proliferation of HepG2 cells by activating AMPK via increasing the AMP/TAN ratio in a LKB1-independent manner. European Journal of Pharmacology. 718(1-3). 235–244. 52 indexed citations
17.
Su, Lijuan, et al.. (2013). Galangin inhibits proliferation of hepatocellular carcinoma cells by inducing endoplasmic reticulum stress. Food and Chemical Toxicology. 62. 810–816. 61 indexed citations
18.
Zhang, Yu‐Qin, Chuanxing Xiao, Biyun Lin, et al.. (2013). Silencing of Pokemon Enhances Caspase-Dependent Apoptosis via Fas- and Mitochondria-Mediated Pathways in Hepatocellular Carcinoma Cells. PLoS ONE. 8(7). e68981–e68981. 29 indexed citations
19.
Lin, Biyun, Chuanxing Xiao, Wenxiu Zhao, et al.. (2012). Enoyl-coenzyme A hydratase short chain 1 silencing attenuates the proliferation of hepatocellular carcinoma by inhibiting epidermal growth factor signaling in vitro and in vivo. Molecular Medicine Reports. 12(1). 1421–1428. 10 indexed citations
20.
Xiao, Chuanxing, Xiaoning Yang, Qingwen Huang, et al.. (2012). ECHS1 acts as a novel HBsAg-binding protein enhancing apoptosis through the mitochondrial pathway in HepG2 cells. Cancer Letters. 330(1). 67–73. 29 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Breakdown of academic impact, for papers by Bangxiang Xie Breakdown of academic impact, for papers by Jiaru Wang Breakdown of academic impact, for papers by Wei‐Heng Xu Breakdown of academic impact, for papers by Shu Dai Breakdown of academic impact, for papers by Nisansala Chandimali Breakdown of academic impact, for papers by Deok Yong Sim Breakdown of academic impact, for papers by Weilian Bao Breakdown of academic impact, for papers by Kang Cui Breakdown of academic impact, for papers by Shenghao Li Breakdown of academic impact, for papers by Haojie Du
Rankless by CCL
2026